US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CITIUS ONCOLOGY INC

0.9549

-0.0251-2.56%

Volume:186.03K

Turnover:184.21K

Market Cap:88.79M

PE:-1.94

High:1.05

Open:0.9986

Low:0.9549

Close:0.9800

52wk High:2.25

52wk Low:0.4912

Shares:92.98M

Float Shares:18.20M

Volume Ratio:2.82

T/O Rate:1.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4931

EPS(LYR):-0.3380

ROE:-126.58%

ROA:-29.12%

PB:2.20

PE(LYR):-2.83

Loading ...

Overview Company News Filings

Citius Oncology FY26 Q2 net loss widens to $26.6 million; revenue rises to $1.7 million

Press Release: Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Citius Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview

Citius Pharma adds $0.9 share conversion option to $3.8 million Citius Oncology note

Citius Oncology issues new warrants for 25555556 shares after USD 11.5 million exercise

Citius Oncology enters up to $25 million senior secured loan facility with Avenue Capital Group

Citius Oncology, Inc. Secures up to $36.5 Million in Debt and Equity Capital to Accelerate Lymphir® Commercialization

THOMSON REUTERS

Citius Oncology announces initial shipment of LYMPHIR to Europe

Citius Oncology ships first international LYMPHIR order to Europe via named patient programs

Citius Oncology risks Nasdaq delisting after shares trade below $1 bid price rule

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/CTOR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CTOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","market":"US","secType":"STK","nameCN":"CITIUS ONCOLOGY INC","latestPrice":0.9549,"timestamp":1790964360393,"preClose":0.98,"halted":0,"volume":186028,"delay":0,"changeRate":-0.025612244897959196,"floatShares":18204800,"shares":92981204,"eps":-0.493118,"marketStatus":"Trading","change":-0.0251,"latestTime":"10-02 14:07:42 EDT","open":0.9986,"high":1.05,"low":0.9549,"amount":184214.9153036,"amplitude":0.097041,"askPrice":0.9599,"askSize":100,"bidPrice":0.9499,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.493118,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.98,"preHourTrading":{"tag":"盘前","latestPrice":1.01,"preClose":0.98,"latestTime":"08:11 EDT","volume":50,"amount":50.5,"timestamp":1790943076398,"change":0.03,"changeRate":0.030612,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":0.98,"latestTime":"19:43 EDT","volume":247,"amount":249.14,"timestamp":1790898194800,"change":0.04,"changeRate":0.040816,"amplitude":0.020408},"volumeRatio":2.824705},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","floatShares":18204800,"roa":"-29.12%","roe":"-126.58%","lyrEps":-0.337956,"volumeRatio":2.824705,"shares":92981204,"dividePrice":0,"high":1.05,"amplitude":0.097041,"preClose":0.98,"low":0.9549,"week52Low":0.4912,"pbRate":"2.20","psRate":"12.50","week52High":2.25,"institutionHeld":0,"latestPrice":0.9549,"committee":-0.980198,"eps":-0.493118,"divideRate":0,"volume":186028,"delay":0,"ttmEps":-0.493118,"open":0.9986,"prevYearClose":1,"prevWeekClose":1.05,"prevMonthClose":1.01,"prevQuarterClose":1.01,"fiveDayClose":1.05,"twentyDayClose":0.7922,"sixtyDayClose":0.7213},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"CTOR","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2026-05-15","symbol":"CTOR","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2026-02-13","symbol":"CTOR","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770958800000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-12-23","symbol":"CTOR","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1766466000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-08-12","symbol":"CTOR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTOR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1758686400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTOR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTOR","date":"2026-10-01","current":-1.936453,"percent":0.775047,"low":-14.569058,"twenty":-5.334154,"median":-3.7576,"eighty":-2.158147,"high":-1.173027,"avg":-3.877503,"sd":1.94786,"marketCap":106816571},"quantilePoints":[{"date":"2024-08-23","current":-7.506449,"twenty":-8.175502,"median":-7.996,"eighty":-7.800179,"marketCap":131199450},{"date":"2024-08-30","current":-6.464428,"twenty":-8.028637,"median":-7.567643,"eighty":-6.639734,"marketCap":126208166},{"date":"2024-09-06","current":-6.847911,"twenty":-7.922567,"median":-7.149219,"eighty":-6.405992,"marketCap":133695091},{"date":"2024-09-13","current":-5.989639,"twenty":-7.726747,"median":-6.50095,"eighty":-6.274513,"marketCap":116938640},{"date":"2024-09-20","current":-6.099206,"twenty":-7.555404,"median":-6.464428,"eighty":-5.97503,"marketCap":119077761},{"date":"2024-09-27","current":-5.222673,"twenty":-7.472896,"median":-6.354861,"eighty":-5.953117,"marketCap":101964790},{"date":"2024-10-04","current":-4.309619,"twenty":-7.088957,"median":-6.190511,"eighty":-5.617113,"marketCap":84138777},{"date":"2024-10-11","current":-3.542653,"twenty":-6.749301,"median":-6.099206,"eighty":-5.018149,"marketCap":69164927},{"date":"2024-10-18","current":-3.944397,"twenty":-6.661648,"median":-5.953117,"eighty":-4.16353,"marketCap":77008372},{"date":"2024-10-25","current":-4.399098,"twenty":-6.559386,"median":-5.916595,"eighty":-4.331532,"marketCap":85885727},{"date":"2024-10-31","current":-4.419185,"twenty":-6.486341,"median":-5.66094,"eighty":-4.324228,"marketCap":86277899},{"date":"2024-11-08","current":-4.602892,"twenty":-6.464428,"median":-5.16789,"eighty":-4.287705,"marketCap":89864492},{"date":"2024-11-15","current":-3.904222,"twenty":-6.464428,"median":-4.930496,"eighty":-4.287705,"marketCap":76224028},{"date":"2024-11-22","current":-3.564201,"twenty":-6.420601,"median":-4.784407,"eighty":-3.944397,"marketCap":69585621},{"date":"2024-11-29","current":-3.356755,"twenty":-6.347557,"median":-4.693102,"eighty":-3.842134,"marketCap":65535551},{"date":"2024-12-06","current":-5.916595,"twenty":-6.296426,"median":-4.747885,"eighty":-3.776395,"marketCap":115512559},{"date":"2024-12-13","current":-3.907874,"twenty":-6.201468,"median":-4.620605,"eighty":-3.842134,"marketCap":76295332},{"date":"2024-12-20","current":-3.871352,"twenty":-6.164946,"median":-4.528752,"eighty":-3.842134,"marketCap":75582291},{"date":"2024-12-27","current":-3.50613,"twenty":-6.135728,"median":-4.435255,"eighty":-3.725263,"marketCap":68451887},{"date":"2025-01-03","current":-4.012144,"twenty":-6.10651,"median":-4.399098,"eighty":-3.717959,"marketCap":84851818},{"date":"2025-01-10","current":-3.992285,"twenty":-6.033466,"median":-4.399098,"eighty":-3.747177,"marketCap":84431834},{"date":"2025-01-17","current":-4.465946,"twenty":-5.967726,"median":-4.376046,"eighty":-3.723807,"marketCap":94449170},{"date":"2025-01-24","current":-4.296782,"twenty":-5.953117,"median":-4.35308,"eighty":-3.739872,"marketCap":90871550},{"date":"2025-01-31","current":-4.262949,"twenty":-5.953117,"median":-4.346141,"eighty":-3.761786,"marketCap":90156026},{"date":"2025-02-07","current":-4.026118,"twenty":-5.938508,"median":-4.309619,"eighty":-3.767526,"marketCap":85147358},{"date":"2025-02-14","current":-4.330615,"twenty":-5.916595,"median":-4.296782,"eighty":-3.799613,"marketCap":91587074},{"date":"2025-02-21","current":-3.72014,"twenty":-5.901986,"median":-4.296782,"eighty":-3.761786,"marketCap":85862882},{"date":"2025-02-28","current":-3.689139,"twenty":-5.807029,"median":-4.262949,"eighty":-3.720436,"marketCap":85147358},{"date":"2025-03-07","current":-3.162119,"twenty":-5.639027,"median":-4.229116,"eighty":-3.689139,"marketCap":72983450},{"date":"2025-03-14","current":-2.294087,"twenty":-5.507546,"median":-4.152992,"eighty":-3.653403,"marketCap":52948777},{"date":"2025-03-21","current":-1.891071,"twenty":-5.317631,"median":-4.127617,"eighty":-3.617985,"marketCap":43646965},{"date":"2025-03-28","current":-2.030577,"twenty":-5.251891,"median":-4.059951,"eighty":-3.565808,"marketCap":46866823},{"date":"2025-04-04","current":-2.191783,"twenty":-5.220193,"median":-4.053963,"eighty":-3.506186,"marketCap":50587548},{"date":"2025-04-11","current":-1.919282,"twenty":-5.198143,"median":-4.02178,"eighty":-3.38992,"marketCap":44298092},{"date":"2025-04-17","current":-2.002676,"twenty":-5.149629,"median":-4.014793,"eighty":-3.224122,"marketCap":46222851},{"date":"2025-04-25","current":-1.987175,"twenty":-5.113107,"median":-3.992285,"eighty":-3.104751,"marketCap":45865089},{"date":"2025-05-02","current":-2.759104,"twenty":-5.076585,"median":-3.944397,"eighty":-2.759104,"marketCap":63681637},{"date":"2025-05-09","current":-2.619599,"twenty":-4.930496,"median":-3.907874,"eighty":-2.693382,"marketCap":60461779},{"date":"2025-05-16","current":-2.437632,"twenty":-4.930496,"median":-3.890787,"eighty":-2.691522,"marketCap":63331031},{"date":"2025-05-23","current":-2.506208,"twenty":-4.784407,"median":-3.875146,"eighty":-2.619599,"marketCap":65112685},{"date":"2025-05-30","current":-2.451953,"twenty":-4.784407,"median":-3.871352,"eighty":-2.502848,"marketCap":63703103},{"date":"2025-06-06","current":-2.671453,"twenty":-4.755189,"median":-3.805483,"eighty":-2.487546,"marketCap":69405829},{"date":"2025-06-13","current":-4.04849,"twenty":-4.660231,"median":-3.776135,"eighty":-2.502848,"marketCap":105182030},{"date":"2025-06-20","current":-4.268817,"twenty":-4.617062,"median":-3.83483,"eighty":-2.506208,"marketCap":110906223},{"date":"2025-06-27","current":-9.639263,"twenty":-4.842843,"median":-3.873249,"eighty":-2.506208,"marketCap":250433407},{"date":"2025-07-03","current":-14.569058,"twenty":-5.098498,"median":-3.876214,"eighty":-2.511716,"marketCap":378512206},{"date":"2025-07-11","current":-8.950744,"twenty":-5.244587,"median":-3.890787,"eighty":-2.545647,"marketCap":232545306},{"date":"2025-07-18","current":-4.40652,"twenty":-5.303022,"median":-3.909331,"eighty":-2.598329,"marketCap":114483843},{"date":"2025-07-25","current":-5.370447,"twenty":-5.303022,"median":-3.944397,"eighty":-2.622079,"marketCap":139527183},{"date":"2025-08-01","current":-7.246465,"twenty":-5.617113,"median":-3.968341,"eighty":-2.631999,"marketCap":188267172},{"date":"2025-08-08","current":-6.066045,"twenty":-5.92757,"median":-3.993409,"eighty":-2.65122,"marketCap":157599217},{"date":"2025-08-15","current":-5.071831,"twenty":-5.92757,"median":-4.017441,"eighty":-2.668242,"marketCap":134797404},{"date":"2025-08-22","current":-4.806444,"twenty":-5.916595,"median":-4.026118,"eighty":-2.679481,"marketCap":127744051},{"date":"2025-08-29","current":-6.251327,"twenty":-5.92757,"median":-4.051227,"eighty":-2.692266,"marketCap":166145638},{"date":"2025-09-05","current":-5.514142,"twenty":-5.933303,"median":-4.056957,"eighty":-2.700326,"marketCap":146552992},{"date":"2025-09-12","current":-5.938837,"twenty":-5.933303,"median":-4.063335,"eighty":-2.734303,"marketCap":157840405},{"date":"2025-09-19","current":-5.498923,"twenty":-5.933303,"median":-4.134553,"eighty":-2.759104,"marketCap":146148523},{"date":"2025-09-26","current":-5.71888,"twenty":-5.924891,"median":-4.16145,"eighty":-2.75929,"marketCap":151994464},{"date":"2025-10-03","current":-5.907415,"twenty":-5.938047,"median":-4.221426,"eighty":-2.76177,"marketCap":157005270},{"date":"2025-10-10","current":-5.750303,"twenty":-5.938047,"median":-4.262949,"eighty":-2.769272,"marketCap":152829598},{"date":"2025-10-17","current":-5.624613,"twenty":-5.934887,"median":-4.265883,"eighty":-2.785269,"marketCap":149489061},{"date":"2025-10-24","current":-5.247544,"twenty":-5.933303,"median":-4.296782,"eighty":-2.845783,"marketCap":139467448},{"date":"2025-10-31","current":-5.436079,"twenty":-5.924891,"median":-4.3032,"eighty":-2.870708,"marketCap":144478254},{"date":"2025-11-07","current":-4.524828,"twenty":-5.916595,"median":-4.309619,"eighty":-2.884898,"marketCap":120259356},{"date":"2025-11-14","current":-4.179182,"twenty":-5.914759,"median":-4.309619,"eighty":-2.896465,"marketCap":111072877},{"date":"2025-11-21","current":-3.550733,"twenty":-5.907415,"median":-4.304871,"eighty":-2.952238,"marketCap":94370189},{"date":"2025-11-28","current":-4.304871,"twenty":-5.907415,"median":-4.296782,"eighty":-3.104751,"marketCap":114413415},{"date":"2025-12-05","current":-3.487889,"twenty":-5.875992,"median":-4.296782,"eighty":-3.112056,"marketCap":92699920},{"date":"2025-12-12","current":-3.550733,"twenty":-5.86799,"median":-4.273096,"eighty":-3.162119,"marketCap":94370189},{"date":"2025-12-19","current":-3.582156,"twenty":-5.84457,"median":-4.262949,"eighty":-3.19281,"marketCap":95205323},{"date":"2025-12-26","current":-3.92117,"twenty":-5.843755,"median":-4.262949,"eighty":-3.21786,"marketCap":97093533},{"date":"2026-01-02","current":-3.424602,"twenty":-5.82283,"median":-4.235196,"eighty":-3.269261,"marketCap":84797846},{"date":"2026-01-09","current":-3.869801,"twenty":-5.792641,"median":-4.210604,"eighty":-3.333795,"marketCap":95821565},{"date":"2026-01-16","current":-3.698571,"twenty":-5.781725,"median":-4.16249,"eighty":-3.356755,"marketCap":91581673},{"date":"2026-01-23","current":-3.835555,"twenty":-5.769156,"median":-4.143012,"eighty":-3.358933,"marketCap":94973587},{"date":"2026-01-30","current":-3.921541,"twenty":-5.737734,"median":-4.109523,"eighty":-3.368971,"marketCap":97102724},{"date":"2026-02-06","current":-3.957191,"twenty":-5.706311,"median":-4.080473,"eighty":-3.382482,"marketCap":97985476},{"date":"2026-02-13","current":-4.206744,"twenty":-5.687458,"median":-4.063335,"eighty":-3.402348,"marketCap":104164740},{"date":"2026-02-20","current":-4.519036,"twenty":-5.682154,"median":-4.084915,"eighty":-3.42469,"marketCap":106812996},{"date":"2026-02-27","current":-4.070867,"twenty":-5.656708,"median":-4.104658,"eighty":-3.426652,"marketCap":96219972},{"date":"2026-03-06","current":-3.996173,"twenty":-5.636748,"median":-4.084915,"eighty":-3.433086,"marketCap":94454468},{"date":"2026-03-13","current":-3.398614,"twenty":-5.624613,"median":-4.070867,"eighty":-3.433086,"marketCap":80330435},{"date":"2026-03-20","current":-2.579959,"twenty":-5.624613,"median":-4.059951,"eighty":-3.389732,"marketCap":60980510},{"date":"2026-03-27","current":-2.020495,"twenty":-5.620211,"median":-4.053963,"eighty":-3.356755,"marketCap":47756885},{"date":"2026-04-02","current":-2.420485,"twenty":-5.602604,"median":-4.04849,"eighty":-3.19281,"marketCap":57211159},{"date":"2026-04-10","current":-2.464929,"twenty":-5.593191,"median":-4.028492,"eighty":-3.034103,"marketCap":58261634},{"date":"2026-04-17","current":-3.007213,"twenty":-5.593191,"median":-4.027305,"eighty":-2.91411,"marketCap":71079194},{"date":"2026-04-24","current":-3.65183,"twenty":-5.573117,"median":-4.02207,"eighty":-3.007213,"marketCap":86315494},{"date":"2026-05-01","current":-3.286198,"twenty":-5.551373,"median":-4.014793,"eighty":-3.009828,"marketCap":77673351},{"date":"2026-05-08","current":-3.364628,"twenty":-5.543629,"median":-3.993409,"eighty":-3.034103,"marketCap":79527131},{"date":"2026-05-15","current":-3.676105,"twenty":-5.530346,"median":-3.975555,"eighty":-3.099835,"marketCap":86889283},{"date":"2026-05-22","current":-1.721465,"twenty":-5.514142,"median":-3.957191,"eighty":-2.91411,"marketCap":73180144},{"date":"2026-05-29","current":-1.674951,"twenty":-5.514142,"median":-3.944397,"eighty":-2.880009,"marketCap":71202779},{"date":"2026-06-05","current":-1.652731,"twenty":-5.501967,"median":-3.944397,"eighty":-2.770947,"marketCap":70258234},{"date":"2026-06-12","current":-1.438015,"twenty":-5.498923,"median":-3.938293,"eighty":-2.752904,"marketCap":61130578},{"date":"2026-06-18","current":-1.370943,"twenty":-5.498923,"median":-3.927802,"eighty":-2.683494,"marketCap":58279289},{"date":"2026-06-26","current":-1.443591,"twenty":-5.48007,"median":-3.921541,"eighty":-2.625689,"marketCap":61367594},{"date":"2026-07-02","current":-1.540487,"twenty":-5.454932,"median":-3.92117,"eighty":-2.581635,"marketCap":65486661},{"date":"2026-07-10","current":-1.57767,"twenty":-5.436079,"median":-3.907874,"eighty":-2.528121,"marketCap":67067342},{"date":"2026-07-17","current":-1.491711,"twenty":-5.431919,"median":-3.890787,"eighty":-2.506208,"marketCap":63413181},{"date":"2026-07-24","current":-1.264673,"twenty":-5.422175,"median":-3.877282,"eighty":-2.478998,"marketCap":53761732},{"date":"2026-07-31","current":-1.255049,"twenty":-5.414466,"median":-3.875146,"eighty":-2.461623,"marketCap":53352614},{"date":"2026-08-07","current":-1.662317,"twenty":-5.404656,"median":-3.870576,"eighty":-2.451127,"marketCap":70665715},{"date":"2026-08-14","current":-1.808426,"twenty":-5.404656,"median":-3.869801,"eighty":-2.413051,"marketCap":76876859},{"date":"2026-08-21","current":-1.532251,"twenty":-5.398372,"median":-3.835192,"eighty":-2.327137,"marketCap":70582031},{"date":"2026-08-28","current":-1.81445,"twenty":-5.372677,"median":-3.833535,"eighty":-2.263085,"marketCap":83581323},{"date":"2026-09-04","current":-1.818813,"twenty":-5.364939,"median":-3.805775,"eighty":-2.179045,"marketCap":83782265},{"date":"2026-09-11","current":-2.08927,"twenty":-5.342906,"median":-3.790526,"eighty":-2.158147,"marketCap":96240673},{"date":"2026-09-18","current":-2.341819,"twenty":-5.341811,"median":-3.772088,"eighty":-2.139391,"marketCap":107874161},{"date":"2026-09-25","current":-2.410696,"twenty":-5.341811,"median":-3.764424,"eighty":-2.158147,"marketCap":111046931},{"date":"2026-10-01","current":-2.31886,"twenty":-5.334154,"median":-3.7576,"eighty":-2.158147,"marketCap":106816571}],"updateTime":1790964461183},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTOR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635030623","title":"Citius Oncology FY26 Q2 net loss widens to $26.6 million; revenue rises to $1.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635030623","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635030623?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:31","pubTimestamp":1778877101,"startTime":"0","endTime":"0","summary":"Citius Oncology posted fiscal Q2 net loss of $26.6 million, widening from $7.7 million year-earlier; net product revenues rose to $1.7 million from no revenue.G&A expenses climbed to $23.6 million from $2.2 million, driven by a $19.7 million one-time CMO contract cancellation charge.Gross profit came in at $1.3 million, implying an 80% margin; cash and cash equivalents totaled $2.6 million at quarter end.Subsequent to quarter end, up to $36.5 million in debt and equity capital was secured, including $11.5 million in warrant exercise proceeds plus a $25 million senior secured term loan facility with $10 million funded at close.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL8kHqVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139","BK4007","CTXR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635985030","title":"Press Release: Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635985030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635985030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:30","pubTimestamp":1778877000,"startTime":"0","endTime":"0","summary":"$5.6 million in net revenue for the first half of fiscal 2026 as LYMPHIR launch progresses. Up to $36.5 million in debt and equity capital secured. Broad payer coverage established with no reimbursement denials. \"Building on the commercial foundation we are establishing in the U.S., we have initiated our first European shipment as part of the international distribution agreements we have in place across 19 markets in Southern Europe, the Middle East, and additional Western and Eastern European territories. At the same time, we continue to strengthen LYMPHIR's long-term value proposition","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","CTOR","R","BK4232","BK4007","BK4139","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634636460","title":"Citius Oncology Inc  expected to post a loss of 1 cent a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634636460","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634636460?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:52","pubTimestamp":1778277126,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc  expected to post a loss of 1cent a share - Earnings Preview Citius Oncology Inc CTOR.OQ CTOR.O is expected to  show a rise in quarterly revenue when it reports  results on May 12 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2QD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTXR","BK4007","CTOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634446257","title":"Citius Pharma adds $0.9 share conversion option to $3.8 million Citius Oncology note","url":"https://stock-news.laohu8.com/highlight/detail?id=2634446257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634446257?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:32","pubTimestamp":1778272344,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals amended promissory note issued by Citius Oncology to align payment terms with subsidiary debt facility subordination.Unpaid principal of USD 3.8 million now due 91 days after Citius Oncology fully repays senior debt and terminates related loan and security agreement.Prior maturity triggers tied to financings were removed; cash prepayment barred before new maturity.Amendment adds optional conversion, subject to Citius Oncology approval, into common stock at USD 0.9 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securitie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL77MGWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4007","BK4139","CTXR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633975228","title":"Citius Oncology issues new warrants for 25555556 shares after USD 11.5 million exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2633975228","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633975228?lang=en_us&edition=fundamental","pubTime":"2026-05-06 08:09","pubTimestamp":1778026188,"startTime":"0","endTime":"0","summary":"Citius Oncology set immediate exercise of outstanding warrants for 12,777,778 shares at USD 0.9 per share, targeting about USD 11.5 million in gross proceeds; closing expected May 6, 2026.New unregistered warrants to buy 25,555,556 shares to be issued as consideration; exercise price USD 0.9; expiry five years after later of stockholder approval or effectiveness of resale registration statement.Company to issue Avenue warrants for 11,111,111 shares at USD 0.9 in connection with a senior credit facility; additional warrant coverage tied to any future tranche funding.Registration statement to be filed covering resale of shares underlying new warrants.Existing December 2025 warrants for 15,697,024 shares to be amended at closing to cut exercise price to USD 0.9 from USD 1.09; exercisable after stockholder approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL6qwFdV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTXR","BK4139","CTOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633975192","title":"Citius Oncology enters up to $25 million senior secured loan facility with Avenue Capital Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2633975192","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633975192?lang=en_us&edition=fundamental","pubTime":"2026-05-06 08:01","pubTimestamp":1778025714,"startTime":"0","endTime":"0","summary":"Citius Oncology entered senior secured term loan credit facility with Avenue Venture Opportunities Fund II, providing up to USD 25 million to support LYMPHIR commercialization.Facility includes USD 10 million initial tranche funded at closing, with up to USD 15 million in additional tranches tied to revenue milestones and liquidity conditions.Avenue received warrants for 11,111,111 shares at USD 0.9 per share, with additional warrant coverage tied to any future tranche funding.Separate warrant exercise agreement with single institutional investor expected to deliver about USD 11.5 million in gross proceeds at USD 0.9 per share, alongside issuance of new unregistered warrants for 25,555,556 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL77bQQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CTOR","CTXR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633938975","title":"Citius Oncology, Inc. Secures up to $36.5 Million in Debt and Equity Capital to Accelerate Lymphir® Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2633938975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633938975?lang=en_us&edition=fundamental","pubTime":"2026-05-06 08:00","pubTimestamp":1778025600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA9STMQJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CTOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631654542","title":"Citius Oncology announces initial shipment of LYMPHIR to Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2631654542","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631654542?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:53","pubTimestamp":1777474438,"startTime":"0","endTime":"0","summary":"Citius Oncology (CTOR), a majority-owned subsidiary of Citius Pharmaceuticals, (CTXR), announced the initial shipment of LYMPHIR to Europe through ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citius-oncology-announces-initial-shipment-of-lymphir-to-europe-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citius-oncology-announces-initial-shipment-of-lymphir-to-europe-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CTXR","BK4007","CTOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631566519","title":"Citius Oncology ships first international LYMPHIR order to Europe via named patient programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2631566519","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631566519?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:09","pubTimestamp":1777464596,"startTime":"0","endTime":"0","summary":"Citius Oncology shipped first international order of LYMPHIR to Europe, expanding access beyond United States.Distribution will run through regional partners via Named Patient Programs under local country rules.LYMPHIR lacks European Medicines Agency marketing authorization, limiting availability to Named Patient Programs.U.S. rollout began in December 2025 following FDA clearance in August 2024 for adult Stage I-III relapsed or refractory CTCL after at least one prior systemic therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL8rcWJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4007","BK4139","CTXR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531306","title":"Citius Oncology risks Nasdaq delisting after shares trade below $1 bid price rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531306","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631531306?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:13","pubTimestamp":1777410801,"startTime":"0","endTime":"0","summary":"Nasdaq notified Citius Oncology on April 22, 2026 that CTOR failed to meet $1 minimum bid price rule for 30 consecutive business days.Stock has until Oct. 19, 2026 to regain compliance by closing at or above $1 for 10 consecutive business days.Failure to cure by deadline could trigger delisting notice, with option to seek a second 180-day cure period if other listing standards are met.Company is evaluating steps to restore compliance, including potential reverse stock split.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLGHwpY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":30,"code":"91000000","status":"200"}]}}